Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Nanosonics Ltd

Healthcare AU NAN

3.27AUD
0.02(0.62%)

Last update at 2026-06-24T02:25:00Z

Day Range

3.243.30
LowHigh

52 Week Range

2.964.77
LowHigh

Fundamentals

  • Previous Close 3.25
  • Market Cap962.49M
  • Volume34773
  • P/E Ratio46.00
  • Dividend Yield-%
  • EBITDA24.66M
  • Revenue TTM207.26M
  • Revenue Per Share TTM0.68
  • Gross Profit TTM 159.92M
  • Diluted EPS TTM0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 22.29M 12.99M 21.60M 1.58M 10.98M
Minority interest - - - - -
Net income 20.68M 12.97M 19.88M 3.74M 8.58M
Selling general administrative 32.09M 26.86M 23.70M 20.28M 16.00M
Selling and marketing expenses 71.87M 65.93M 60.95M 47.88M 37.56M
Gross profit 155.66M 133.99M 132.17M 91.31M 79.14M
Reconciled depreciation 8.07M 7.63M 7.14M 5.73M 4.43M
Ebit 23.75M 14.09M 22.37M 2.13M 11.32M
Ebitda 31.82M 21.72M 29.50M 7.86M 15.75M
Depreciation and amortization 8.07M 7.63M 7.14M 5.73M 4.43M
Non operating income net other - - - - -
Operating income 8.93M 9.12M 17.79M 1.84M 9.78M
Other operating expenses 190.00M 160.90M 146.36M 118.54M 92.32M
Interest expense 1.46M 1.10M 0.77M 0.56M 0.34M
Tax provision 1.61M 0.01M 1.71M -2.16400M 2.41M
Interest income 5.94M 4.97M 2.39M 0.35M 0.22M
Net interest income 4.48M 3.87M 1.96M -0.20400M 0.22M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.61M 0.01M 1.71M -2.16400M 2.41M
Total revenue 198.93M 171.56M 167.51M 119.73M 101.83M
Total operating expenses 146.73M 133.23M 121.30M 96.25M 75.19M
Cost of revenue 43.27M 37.58M 35.35M 28.41M 22.70M
Total other income expense net 13.36M 3.87M 1.64M 0.99M 2.38M
Discontinued operations - - - - -
Net income from continuing ops 20.68M 12.97M 19.88M 3.74M 8.58M
Net income applicable to common shares 20.68M 12.97M 19.88M 3.74M 8.58M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 272.48M 241.88M 219.92M 187.67M 162.30M
Intangible assets 0.00100M 0.01M 0.10M 0.22M 0.28M
Earning assets - - - - -
Other current assets 0.81M 7.38M 0.39M 0.24M 0.17M
Total liab 62.57M 59.67M 56.06M 48.98M 26.74M
Total stockholder equity 209.91M 182.20M 163.86M 138.69M 135.57M
Deferred long term liab - - - 0.21M 0.13M
Other current liab - 14.34M 18.59M 16.96M 12.46M
Common stock - 114.55M 114.21M 113.86M 113.54M
Capital stock 114.86M 114.55M 114.21M 113.86M 113.54M
Retained earnings 58.39M 37.71M 24.74M 4.86M 1.12M
Other liab - - - 10.66M 6.18M
Good will - - - - -
Other assets - 0.00000M 15.36M 13.62M 10.38M
Cash 161.29M 129.55M 112.16M 94.51M 96.03M
Cash and equivalents - - 1.84M 2.09M 4.12M
Total current liabilities 39.79M 32.23M 33.03M 29.16M 19.54M
Current deferred revenue - 11.27M 7.80M 6.90M 3.55M
Net debt - -120.24900M -101.43900M -82.80000M -93.53600M
Short term debt - 3.14M 2.88M 2.55M 1.48M
Short long term debt - - - - -
Short long term debt total - 9.30M 10.72M 11.71M 2.49M
Other stockholder equity - 0.00000M -138.95300M -118.71400M -114.65600M
Property plant equipment - - 22.50M 22.58M 9.33M
Total current assets 225.32M 197.79M 181.62M 151.25M 142.31M
Long term investments - - - - -
Net tangible assets - - - 138.47M 135.29M
Short term investments - - 88.48M 72.75M 73.00M
Net receivables 32.31M 40.62M 38.75M 28.39M 28.36M
Long term debt - - - - -
Inventory 18.63M 20.24M 25.49M 22.61M 11.87M
Accounts payable 1.53M 3.47M 3.76M 2.74M 2.05M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 29.94M 24.91M 19.98M 20.91M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.06M 1.18M 0.41M 0.28M 0.20M
Deferred long term asset charges - - - - -
Non current assets total 47.16M 44.08M 38.30M 36.42M 19.99M
Capital lease obligations 7.69M 9.30M 10.72M 11.71M 2.49M
Long term debt total - - 7.84M 9.16M 1.01M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -8.70700M -2.36400M -3.54100M -6.90200M -1.38100M
Change to liabilities - - 0.00000M 5.42M 1.77M
Total cashflows from investing activities -8.70700M -2.36400M -3.54100M -6.90200M -1.38100M
Net borrowings - - - -2.03500M -1.29800M
Total cash from financing activities -3.30200M -3.00600M -2.71200M -1.97300M -1.03400M
Change to operating activities - - - 1.14M 0.16M
Net income 20.68M 12.97M 19.88M 3.74M 8.58M
Change in cash 32.09M 17.39M 17.65M -1.51500M 4.25M
Begin period cash flow 129.55M 112.16M 94.51M 96.03M 91.78M
End period cash flow 161.64M 129.55M 112.16M 94.51M 96.03M
Total cash from operating activities 43.98M 22.78M 23.31M 6.70M 7.32M
Issuance of capital stock 0.31M 0.33M 0.36M 0.32M 0.36M
Depreciation - 7.63M 7.01M 5.48M 4.08M
Other cashflows from investing activities 0.02M 0.15M 0.03M 0.06M -0.01000M
Dividends paid - - - - -
Change to inventory 1.45M 3.13M -3.01200M -10.74500M -1.51000M
Change to account receivables 2.43M -0.95800M -8.99800M 4.22M -10.90300M
Sale purchase of stock 0.31M 0.33M 0.36M 0.32M 0.36M
Other cashflows from financing activities -3.61200M -3.34000M -3.06800M -2.28900M -1.31900M
Change to netincome - - - -2.81700M 4.79M
Capital expenditures 8.72M 2.52M 3.57M 6.97M 1.37M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 11.32M 3.24M -12.01000M -6.52100M -12.41300M
Stock based compensation - 4.26M 5.46M 2.82M 2.57M
Other non cash items 32.66M -1.06000M -3.57600M -2.53100M -5.34100M
Free cash flow 35.26M 20.27M 19.74M -0.27100M 5.95M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NAN
Nanosonics Ltd		 0.02 0.62% 3.27 46.00 45.66 4.64 4.34 3.86 25.27
RMD
Resmed Inc		 0.81 3.01% 27.86 18.03 16.42 6.94 4.35 4.93 12.53
FPH
Fisher & Paykel Healthcare Corporation Ltd		 -0.03 0.10% 30.83 49.06 42.92 8.11 10.78 9.75 28.11
ANN
Ansell Ltd		 0.40 1.34% 30.30 22.72 13.07 2.09 1.50 1.76 11.71
SDI
SDI Ltd		 - -% 1.40 13.90 5.06 1.48 1.60 1.59 8.65

Reports Covered

Stock Research & News

View All

Profile

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Ltd

Building A, Macquarie Park, NSW, Australia, 2113

Key Executives

Name Title Year Born
Mr. Michael C. Kavanagh BSc, M.B.A. CEO, Pres, MD & Exec. Director NA
Mr. McGregor Grant BEc, C.A., CA, FCIS, GAICD CFO & Company Sec. NA
Mr. Rod Lopez M.B.A. Chief Operating Officer NA
Dr. Steven Farrugia BE, Ph.D. Chief Technology Officer NA
Mr. David N. Morris Chief Strategy Officer & Regional Pres Asia Pacific NA
Matthew Carbines B.Com., L.L.B. Gen. Counsel NA
Mr. Matthew Lipscombe B.E., B.Sc., M.B.A. Chief Marketing Officer NA
Ms. Jodi Sampson Chief People & Culture Officer NA
Mr. Vincent Wang Head of Global Customer Support & Technical Services NA
Mr. Keith Koby Sr. VP of Sales - North America NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.